Use of a Combination of Allergen Immunotherapy and Omalizumab for Prevention of Anaphylaxis

Purpose of review Allergen immunotherapy (AIT) is aimed at the etiological treatment of respiratory allergy and Hymenoptera venom allergy, while it is still under investigation for food allergy. The incidence of anaphylactic reactions to AIT is generally low, but may hamper its completion and makes needed preventive treatment.